SNMMI: AI can avoid patient misidentification on PET/CT
June 25, 2018 -- PHILADELPHIA - Artificial intelligence (AI) software can accurately predict a patient's gender on PET/CT scans, a capability that could help to avoid patient identification errors in PACS, according to research presented on Saturday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.  Discuss
SNMMI: New therapy aids patients with neuroendocrine tumors
June 25, 2018 -- PHILADELPHIA - Researchers from the U.S. and China are reporting early success with a new, long-lasting theranostic radionuclide therapy for patients with advanced metastatic neuroendocrine tumors. Study results were presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.  Discuss
SNMMI 2018: A year of promotion and ongoing challenges
June 22, 2018 -- The upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Philadelphia will mark the end of President Dr. Bennett Greenspan's one-year term. recently spoke with Greenspan to hear his thoughts on the current state of nuclear medicine and SNMMI's path to the future.  Discuss
ASNC releases new guidelines for SPECT MPI
June 21, 2018 -- The American Society of Nuclear Cardiology (ASNC) has published its 2018 guidelines for SPECT myocardial perfusion imaging (MPI). The document features updates on hardware, collimators, and cadmium zinc telluride gamma cameras, along with several new sections.  Discuss
Are amyloid PET scans ready for the clinical setting?
June 15, 2018 -- The use of PET scans to confirm the presence of dementia-inducing amyloid plaque in the brain may be ready for routine clinical use, based on a prospective study published online June 11 in JAMA Neurology. Researchers found that both positive and negative results influenced the diagnosis and treatment of patients with and without dementia.  Discuss
CMS again declines coverage for NaF-PET scans
June 7, 2018 -- Despite numerous studies and years of research into the benefits of PET imaging with sodium fluoride (NaF) for cancer patients with bone metastases, the U.S. Centers for Medicare and Medicaid Services (CMS) has again rejected reimbursement coverage.  Discuss
Novel PET tracer shows promise for neuroendocrine tumors
June 7, 2018 -- The ability to detect cancerous gastrointestinal and pancreatic neuroendocrine tumors soon might get a boost from a radiolabeled PET tracer that is better able to bind to tumors, according to a study published in the June issue of the Journal of Nuclear Medicine.  Discuss
PET directs esophageal cancer treatment for better outcomes
June 5, 2018 -- By using PET scans to assess the efficacy of chemotherapy for esophageal cancer early in the course of treatment, clinicians can change their treatment strategy if necessary and greatly improve patient outcomes, according to a presentation at the American Society of Clinical Oncology annual meeting in Chicago.  Discuss
PET tracer may aid diagnosis of inflammatory bowel disease
June 4, 2018 -- Researchers have used a new PET tracer to identify areas of inflammation in the colon in mice. The technique could eventually be able to improve the visualization and diagnosis of inflammatory bowel disease in humans, according to an article published in the June issue of the Journal of Nuclear Medicine.  Discuss
Immuno-PET tracer offers hope for early cancer treatment
May 17, 2018 -- Researchers are developing a PET radiotracer designed to adhere to and illuminate immune cells in cancer patients. They believe it could offer an earlier look at treatment response compared with tracers such as FDG that focus on cancer cells, according to a study published May 14 in the Journal of Clinical Investigation.  Discuss